Das S, Dash B, Premji T, Chen J
Int J Mol Sci. 2023; 24(13).
PMID: 37445721
PMC: 10341481.
DOI: 10.3390/ijms241310546.
Laderach D, Compagno D
Front Immunol. 2023; 13:1104625.
PMID: 36703969
PMC: 9872792.
DOI: 10.3389/fimmu.2022.1104625.
Zhu G, Lai Y, Chen F, Qian J, Lin H, Yuan D
Dis Markers. 2022; 2022:6306845.
PMID: 35990248
PMC: 9391161.
DOI: 10.1155/2022/6306845.
Peixoto A, Miranda A, Santos L, Ferreira J
J Exp Clin Cancer Res. 2022; 41(1):143.
PMID: 35428302
PMC: 9013178.
DOI: 10.1186/s13046-022-02335-z.
Menkhorst E, Than N, Jeschke U, Barrientos G, Szereday L, Dveksler G
Front Immunol. 2022; 12:784473.
PMID: 34975875
PMC: 8715898.
DOI: 10.3389/fimmu.2021.784473.
Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.
Laderach D, Compagno D
Cancers (Basel). 2021; 13(18).
PMID: 34572756
PMC: 8469970.
DOI: 10.3390/cancers13184529.
Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
Bozward A, Warricker F, Oo Y, Khakoo S
Front Immunol. 2021; 12:643310.
PMID: 33995362
PMC: 8120158.
DOI: 10.3389/fimmu.2021.643310.
Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients.
Wang J, Han K, Zhang C, Chen X, Li Y, Zhu L
Biosci Rep. 2021; 41(5).
PMID: 33988674
PMC: 8164111.
DOI: 10.1042/BSR20210583.
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.
Kandel S, Adhikary P, Li G, Cheng K
Cancer Lett. 2021; 510:67-78.
PMID: 33895262
PMC: 8168453.
DOI: 10.1016/j.canlet.2021.04.011.
Aberrantly Expressed Galectin-9 Is Involved in the Immunopathogenesis of Anti-MDA5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Liang L, Zhang Y, Shen Y, Song A, Li W, Ye L
Front Cell Dev Biol. 2021; 9:628128.
PMID: 33842457
PMC: 8027128.
DOI: 10.3389/fcell.2021.628128.
Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma.
Boehne C, Behrendt A, Meyer-Bahlburg A, Boettcher M, Drube S, Kamradt T
PLoS One. 2021; 16(4):e0249605.
PMID: 33822811
PMC: 8023500.
DOI: 10.1371/journal.pone.0249605.
Tim-3 suppresses autoimmune hepatitis via the p38/MKP-1 pathway in Th17 cells.
Wu H, Tang S, Zhou M, Xue J, Yu Z, Zhu J
FEBS Open Bio. 2021; 11(5):1406-1416.
PMID: 33728805
PMC: 8091815.
DOI: 10.1002/2211-5463.13148.
Galectin-9: A Suppressor of Atherosclerosis?.
Yu J, Zhu R, Yu K, Wang Y, Ding Y, Zhong Y
Front Immunol. 2020; 11:604265.
PMID: 33250901
PMC: 7672040.
DOI: 10.3389/fimmu.2020.604265.
Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials.
Compagno D, Tiraboschi C, Garcia J, Rondon Y, Corapi E, Velazquez C
Biomolecules. 2020; 10(5).
PMID: 32408492
PMC: 7277089.
DOI: 10.3390/biom10050750.
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.
Langhans B, Nischalke H, Kramer B, Dold L, Lutz P, Mohr R
Cancer Immunol Immunother. 2019; 68(12):2055-2066.
PMID: 31724091
PMC: 11028391.
DOI: 10.1007/s00262-019-02427-4.
Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy.
Villani R, Vendemiale G, Serviddio G
Int J Mol Sci. 2018; 20(1).
PMID: 30583555
PMC: 6337751.
DOI: 10.3390/ijms20010049.
Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans.
Giovannone N, Liang J, Antonopoulos A, Geddes Sweeney J, King S, Pochebit S
Nat Commun. 2018; 9(1):3287.
PMID: 30120234
PMC: 6098069.
DOI: 10.1038/s41467-018-05770-9.
Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells.
Safinia N, Grageda N, Scotta C, Thirkell S, Fry L, Vaikunthanathan T
Front Immunol. 2018; 9:354.
PMID: 29535728
PMC: 5834909.
DOI: 10.3389/fimmu.2018.00354.
The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment.
Chen T, Chen C, Wang C, Lin P, Yang T, Lou P
Sci Rep. 2017; 7(1):10349.
PMID: 28871094
PMC: 5583393.
DOI: 10.1038/s41598-017-10386-y.
Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?.
Crux N, Elahi S
Front Immunol. 2017; 8():832.
PMID: 28769934
PMC: 5513977.
DOI: 10.3389/fimmu.2017.00832.